Literature DB >> 10526073

Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis.

J Ayerbe1, R D Lobato, J de la Cruz, R Alday, J J Rivas, P A Gómez, A Cabrera.   

Abstract

The authors undertook a follow-up study of 286 patients who underwent surgical treatment for intracranial meningioma between 1973 and 1994, in order to analyse clinical, radiological, topographic, histopathological and therapeutic factors significantly influencing tumour recurrence. All patients were followed by using either computed tomography (CT) or magnetic resonance from 3 months to 17 years since first surgery (mean follow-up: 4.1 years). Forty-four (15.4%) recurrences were detected during this time period. Overall recurrence rates were 14%, 37% and 61% at 5, 10 and 15 years, respectively. Factors significantly associated with tumour relapse in bivariate analysis were: tumour location at petroclival and parasagittal (middle third) regions, incomplete surgical resection (assessed by Simpson's classification), atypical and malignant histological types (WHO classification), presence of nucleolar prominence, presence of more than 2 mitosis per 10 high-power fields, and heterogeneous tumour contrast enhancement on the CT scan. The multivariate analysis using the Cox's proportional hazards model identified the following risk factors for recurrence: incomplete surgical resection (Relative risk: 2.2; 95% Confidence interval: 1.33-3.64), non conventional histological type (RR: 2.13; 95%CI: 1-4.53), heterogeneous contrast enhancement on the CT scan (RR: 2.25; 95%CI: 1.1-4.72) and presence of more than 2 mitosis per 10 high-power fields (RR: 2.28; 95%CI: 0.99-5.27). Patients without any of these features showed low recurrence rates (4% and 18% at 5 and 10 years), and thus, they need less clinical and radiological controls through the follow-up than patients with some of these risk factors.

Entities:  

Mesh:

Year:  1999        PMID: 10526073     DOI: 10.1007/s007010050398

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  43 in total

1.  WHO grade II and III meningiomas: a study of prognostic factors.

Authors:  Anne Durand; François Labrousse; Anne Jouvet; Luc Bauchet; Michel Kalamaridès; Philippe Menei; Robert Deruty; Jean Jacques Moreau; Michelle Fèvre-Montange; Jacques Guyotat
Journal:  J Neurooncol       Date:  2009-06-27       Impact factor: 4.130

2.  Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings.

Authors:  C G Filippi; M A Edgar; A M Uluğ; J C Prowda; L A Heier; R D Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 3.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

4.  Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas.

Authors:  Y Kamei; M Watanabe; T Nakayama; K Kanamaru; S Waga; T Shiraishi
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

Review 5.  Long term experience of gamma knife radiosurgery for benign skull base meningiomas.

Authors:  W Kreil; J Luggin; I Fuchs; V Weigl; S Eustacchio; G Papaefthymiou
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

6.  Value of K i -67 Labeling Index in Predicting Recurrence of WHO Grade I Cranial Base Meningiomas.

Authors:  Jose Gabrielle Matias; Ignacio Jusue-Torres; Brendan Martin; Ankush Bajaj; Ewa Borys; Edward Melian; Kevin Barton; Douglas E Anderson; Vikram C Prabhu
Journal:  J Neurol Surg B Skull Base       Date:  2018-09-06

7.  5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo.

Authors:  Pablo A Valdes; Kimon Bekelis; Brent T Harris; Brian C Wilson; Frederic Leblond; Anthony Kim; Nathan E Simmons; Kadir Erkmen; Keith D Paulsen; David W Roberts
Journal:  Neurosurgery       Date:  2014-03       Impact factor: 4.654

Review 8.  Opportunities for clinical research in meningioma.

Authors:  Michael A Vogelbaum; C Leland Rogers; Mark A Linskey; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-11       Impact factor: 4.130

Review 9.  Intracranial meningiomas of atypical (WHO grade II) histology.

Authors:  Leland Rogers; Mark Gilbert; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-08-26       Impact factor: 4.130

10.  Bone involvement predicts poor outcome in atypical meningioma.

Authors:  Darlene Gabeau-Lacet; Manish Aghi; Rebecca A Betensky; Fred G Barker; Jay S Loeffler; David N Louis
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.